-
Products & Services
-
-
News & Events
DXneb™-Solo Piezoelectric Mesh Nebulizer (MESH)
Product Details
| Product Picture | Features |
|---|---|
 |
• Advanced vibrating sieve hole atomization drug delivery technology
Silent (rarely inhaled when the child cries)
• Design advantages of installed piping to improve suction efficiency
High efficiency (high lung deposition rate, fast, good curative effect)
• No additional air supply required (battery driven)
• Screen vibration produces fog
• uniform particle size
• Small drug residues ( <0.1ml,20ml Medicine)
|
Piezoelectric Mesh Nebulizer
Medical piezoelectric vibrating-mesh nebulizer designed for in-hospital therapy, suitable for spontaneous breathing and assisted ventilation patients, with uniform particles, low drug residue and quiet operation.
01. One key operation
Simple and convenient, it can be atomized with just one tap, and it can be easily used by children.
02. Smooth fog
The proportion of particles below 5 m is high, the atomization rate is moderate, the particles are fine, and the throat is not choked.
03. Skin friendly and no peculiar smell
Available with mask and mouthpiece options, with pediatric and adult masks to suit different departments and patient populations.
04. Dual power supply mode
Built-in battery, long battery life, can use the universal charging interface for charging.
Product advantages
- Advanced vibrating screen hole atomization drug delivery technology,
- Silence (little inhalation of medicine when the child is crying),
- The advantages of the Disibo atomizer in the installation pipeline,
- High efficiency (high lung deposition rate, fast, good curative effect),
- Safety (no aerosol pollution) authority certification and recommend (international article data support, global new crown recommend use)
- Suitable for patients with the whole treatment: invasive/non-invasive/nasal high flow/high frequency ventilation/oxygen side atomization;
- Suitable for various departments, focusing on acute and severe cases;
- Efficient treatment, save patient costs, increase the hospital bed turnover rate;
- Nebulizers designated for use during the new crown outbreak;
- Preferred Carriers for Aerosolized Administration
atomization particle size analysis
Analysis of Reachable Positions of Different Drug Aerosol Particles
| Particle size | Deposition |
| > 10μm | 100% deposited in oropharynx |
| 5-10μm | upper airway and upper airway |
| 2-5μm | lower respiratory tract |
| 1-2μm | alveoli |
| <1μm | Not deposited, exhaled |
Product Positioning
DSB Medical’s piezoelectric vibrating-mesh nebulizer system is engineered for in-hospital treatment — covering ICU, NICU, pediatrics, respiratory and elderly care. It serves spontaneously breathing patients as well as those on assisted ventilation (invasive/non-invasive mechanical ventilation, high-flow nasal cannula, tracheostomy and ventilator circuits). Series: DSB® Solo / DSB® Pro. Home use is a future extension.
Key In-hospital Advantages
- Suitable for mechanical ventilation: stays in the breathing circuit, no need to remove the flow sensor or adjust ventilator parameters; supports invasive/non-invasive/high-flow/tracheostomy.
- Near-silent: <35 dB at 0.3 m — ideal for neonatal, pediatric and night-time therapy.
- Low drug residue: <0.1 ml (per 3 ml dose) vs 0.8–1.2 ml for compressor nebulizers.
- Uniform particles: 0.5–10 μm (optimal 2.5–4.7 μm), reaching the lung target.
- No heat, no protein denaturation: preserves drug molecular structure, supporting biologics and gene therapy.
- No parameter adjustment: just 2 steps per treatment (add medication + switch).
Product Parameters
| Aerosolization rate (graded) | Low ≥0.1 / Medium ≥0.2 / High ≥0.25 mL/min |
| Medication cup capacity | 20 ml |
| Medication cup weight | 21 g |
| Battery life | ≥60 minutes |
| Vibration frequency | 110–130 kHz |
| Mesh | >3,000 precision conical orifices per mesh |
| Noise | <35 dB (0.3 m) |
Applicable Scenarios
Departments: ICU, NICU, pediatrics, respiratory and elderly care. Routes: invasive mechanical ventilation, non-invasive ventilator, high-flow nasal cannula, tracheostomy, and spontaneous breathing (mouthpiece/mask).
Clinical Backing
- Nebulized tobramycin: alveolar lining fluid concentration 250× higher than IV at 2.5 h.
- 90.9% Pseudomonas aeruginosa (PA) clearance at 28 days (Chest, 2022).
- Expert consensus on nebulization during mechanical ventilation recommends vibrating-mesh nebulizers (Grade E).
FAQ
1. How to nebulize safely during mechanical ventilation?
Keep the nebulizer in the breathing circuit; no need to remove the flow sensor or adjust ventilator parameters.
2. Which patients is it suitable for?
Spontaneously breathing patients and assisted-ventilation patients (invasive/non-invasive ventilator, high-flow nasal cannula, tracheostomy).
3. How much drug residue is left?
<0.1 ml (per 3 ml dose), lower than the 0.8–1.2 ml of compressor nebulizers.
4. Is it noisy?
<35 dB, nearly silent — suitable for neonatal, pediatric and night-time use.
5. Why vibrating mesh over compressor or ultrasonic?
Uniform particles, no heat denaturation, no extra gas source, no ventilator interference, and support for biologics and gene therapy.
DXneb™-Solo is a registered model (NMPA registration: Su-Xie-Zhu-Zhun 20262080132).
View the complete DXneb™ brand page.
Next
Recommended Products
If you have more needs?
Welcome your message, we will reply you in time.
355 Longjin Road, Changzhou Economic Development Zone, Jiangsu Province, China
DSB Medical – Medical Device Manufacturer. Privacy Policy | SEO